CN109182495A - 一种用于无创产前检测双侧杯状耳畸形的基因芯片、试剂盒及基因芯片的应用方法 - Google Patents
一种用于无创产前检测双侧杯状耳畸形的基因芯片、试剂盒及基因芯片的应用方法 Download PDFInfo
- Publication number
- CN109182495A CN109182495A CN201811071168.6A CN201811071168A CN109182495A CN 109182495 A CN109182495 A CN 109182495A CN 201811071168 A CN201811071168 A CN 201811071168A CN 109182495 A CN109182495 A CN 109182495A
- Authority
- CN
- China
- Prior art keywords
- probe
- genetic chip
- bilateral
- treating congenital
- cup ear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002068 genetic effect Effects 0.000 title claims abstract description 71
- 206010010356 Congenital anomaly Diseases 0.000 title claims abstract description 65
- 230000002146 bilateral effect Effects 0.000 title claims abstract description 56
- 238000001514 detection method Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 22
- 239000000523 sample Substances 0.000 claims abstract description 135
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- 238000002493 microarray Methods 0.000 claims abstract description 9
- 239000002299 complementary DNA Substances 0.000 claims abstract description 4
- 239000002773 nucleotide Substances 0.000 claims description 30
- 125000003729 nucleotide group Chemical group 0.000 claims description 30
- 238000009396 hybridization Methods 0.000 claims description 24
- 238000004140 cleaning Methods 0.000 claims description 14
- 238000003908 quality control method Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- 230000008901 benefit Effects 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 3
- 239000002274 desiccant Substances 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 3
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 3
- 230000001079 digestive effect Effects 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 239000006166 lysate Substances 0.000 claims description 2
- 208000003217 Tetany Diseases 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 230000001605 fetal effect Effects 0.000 abstract description 3
- 238000003793 prenatal diagnosis Methods 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 238000011017 operating method Methods 0.000 abstract description 2
- 210000003754 fetus Anatomy 0.000 description 15
- 238000012360 testing method Methods 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 238000001179 sorption measurement Methods 0.000 description 12
- 208000032170 Congenital Abnormalities Diseases 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000008774 maternal effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 210000000959 ear middle Anatomy 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 2
- 208000028782 Hereditary disease Diseases 0.000 description 2
- 102100029019 Homeobox protein HMX1 Human genes 0.000 description 2
- 101000986308 Homo sapiens Homeobox protein HMX1 Proteins 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 208000024556 Mendelian disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 210000000883 ear external Anatomy 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000933 neural crest Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 208000005831 Congenital Microtia Diseases 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010014016 Ear malformation Diseases 0.000 description 1
- 241001237732 Microtia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000000984 branchial region Anatomy 0.000 description 1
- 230000022159 cartilage development Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000005574 cross-species transmission Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 206010027555 microtia Diseases 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001982 neural crest cell Anatomy 0.000 description 1
- 230000014390 neural crest cell migration Effects 0.000 description 1
- 210000001020 neural plate Anatomy 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
检测结果 | 数量 | 预测结果 | 实际结果 |
阳性 | 42例 | 患有双侧杯状耳畸形 | 双侧杯状耳畸形 |
阴性 | 141例 | 未患有双侧杯状耳畸形 | 表型正常 |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811071168.6A CN109182495B (zh) | 2018-09-14 | 2018-09-14 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
PCT/CN2019/105454 WO2020052603A1 (zh) | 2018-09-14 | 2019-09-11 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片、试剂盒及基因芯片的应用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811071168.6A CN109182495B (zh) | 2018-09-14 | 2018-09-14 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109182495A true CN109182495A (zh) | 2019-01-11 |
CN109182495B CN109182495B (zh) | 2021-02-23 |
Family
ID=64911249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811071168.6A Active CN109182495B (zh) | 2018-09-14 | 2018-09-14 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN109182495B (zh) |
WO (1) | WO2020052603A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020052603A1 (zh) * | 2018-09-14 | 2020-03-19 | 张娇 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片、试剂盒及基因芯片的应用方法 |
CN113462768A (zh) * | 2021-07-29 | 2021-10-01 | 中国医学科学院整形外科医院 | 一种利用ddPCR检测小耳畸形患者ECR区域的拷贝数的引物及试剂盒 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103436609A (zh) * | 2013-08-13 | 2013-12-11 | 康盈创新生物技术(北京)有限公司 | 一种无创产前诊断先天性耳聋遗传病的方法 |
CN109182495B (zh) * | 2018-09-14 | 2021-02-23 | 张娇 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片和试剂盒 |
-
2018
- 2018-09-14 CN CN201811071168.6A patent/CN109182495B/zh active Active
-
2019
- 2019-09-11 WO PCT/CN2019/105454 patent/WO2020052603A1/zh active Application Filing
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020052603A1 (zh) * | 2018-09-14 | 2020-03-19 | 张娇 | 一种用于无创产前检测双侧杯状耳畸形的基因芯片、试剂盒及基因芯片的应用方法 |
CN113462768A (zh) * | 2021-07-29 | 2021-10-01 | 中国医学科学院整形外科医院 | 一种利用ddPCR检测小耳畸形患者ECR区域的拷贝数的引物及试剂盒 |
CN113462768B (zh) * | 2021-07-29 | 2023-05-30 | 中国医学科学院整形外科医院 | 一种利用ddPCR检测小耳畸形患者ECR区域的拷贝数的引物及试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
WO2020052603A1 (zh) | 2020-03-19 |
CN109182495B (zh) | 2021-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110291212A (zh) | 使用核酸片段的诊断应用 | |
CN108300808A (zh) | 一种非洲猪瘟病毒荧光pcr检测试剂盒、制备方法及使用方法 | |
CN104450901B (zh) | 快速诊断川崎病的核酸标记物及其试剂盒 | |
CN106868125B (zh) | 用于幼年型骨质疏松症检测的试剂盒 | |
TWI314582B (en) | Methods for detecting papillomavirus dna in blood plasma and serum | |
CN105543408B (zh) | 冠心病早期诊断标志物 | |
TR201815847T4 (tr) | İnvazif olmayan kanser teşhisi. | |
JP2021502069A5 (zh) | ||
CN107955836A (zh) | 用于肺癌相关基因shox2甲基化检测的引物对、试剂盒及方法 | |
CN109182495A (zh) | 一种用于无创产前检测双侧杯状耳畸形的基因芯片、试剂盒及基因芯片的应用方法 | |
CN108642156A (zh) | 一种t790m基因突变的数字pcr检测试剂盒及其检测方法 | |
CN108676868A (zh) | 一组1型糖尿病标志物及其应用 | |
WO2020052602A1 (zh) | 一种用于无创产前评估半侧颜面短小综合征的基因芯片、试剂盒及基因芯片的应用方法 | |
CN109355406B (zh) | 一种基于血液游离核酸的检测结核分枝杆菌的试剂盒 | |
CN110511995B (zh) | 一组结核病标志物及其应用 | |
Worsham et al. | Molecular approaches to identification of tissue contamination in surgical pathology sections | |
JP2016077234A (ja) | 子宮内膜症の早期診断のための診断キット、診断マーカー及び検出方法 | |
CN109735612A (zh) | 川崎病冠状动脉瘤并发症的生物分子标志物及其试剂盒 | |
CN112899360B (zh) | 一种检测特雷彻·柯林斯综合征发生概率的组合物的应用方法 | |
JP3771502B2 (ja) | 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法 | |
CN116377058A (zh) | 一种圆锥角膜的检测panel及其应用 | |
CN104087671A (zh) | 一种用于检测人21号染色体数目的试剂盒 | |
KR20180081445A (ko) | 핵산의 신속 검출법 및 이를 이용한 질병의 신속 진단 방법 | |
Yang et al. | Systematic review of noninvasive prenatal diagnosis for abnormal chromosome genetic diseases using free fetal DNA in maternal plasma | |
CN107312867B (zh) | 诊断甲状腺功能减退的snp及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230815 Address after: Room 12, Room 209, 2nd Floor, Building 10, Yard 2, Shangjialou Road, Chaoyang District, Beijing, 100028 Patentee after: Pan Asia Runkang (Beijing) Biotechnology Co.,Ltd. Address before: 1-4-901, Yongjing Siji, Xili, Xihuang village, Tiancun Road, Shijingshan District, Beijing Patentee before: Zhang Jiao |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240226 Address after: 210000 No.87 dingjiaqiao, Gulou District, Nanjing, Jiangsu Province Patentee after: Zhang Jiao Country or region after: China Address before: Room 12, Room 209, 2nd Floor, Building 10, Yard 2, Shangjialou Road, Chaoyang District, Beijing, 100028 Patentee before: Pan Asia Runkang (Beijing) Biotechnology Co.,Ltd. Country or region before: China |